EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Fructosamine and glycated hemoglobin as biomarkers of glycemic control in people with type 2 diabetes mellitus and cancer (GlicoOnco study)

Marcos Tadashi Kakitani Toyoshima, Priscilla Cukier, Aline Santos Damascena, Rafael Loch Batista, Fernanda de Azevedo Correa, Eduardo Zanatta Kawahara, Carlos André Minanni, Ana O Hoff, Marcia Nery

Clinics · 2023-01 · 78 · 100240

DOI: 10.1016/j.clinsp.2023.100240 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinics, 2023-01. Verfasst von Marcos Tadashi Kakitani Toyoshima und 8 weiteren Autor:innen. Beteiligte Einrichtung: Serviço de Onco-Endocrinologia, Instituto do Câncer do Estado de São Paulo Octávio Frias de Oliveira; Hospital das Clínicas da Faculdade de Medicina …. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Hypoalbuminemia, Neoplasms, Diabetes Mellitus. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Endocrine Society.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Glycemic control is important to avoid diabetes complications in individuals with cancer. There is no evidence for HbA1c and fructosamine as reliable biomarkers in these conditions. There are particularities in caring for patients with diabetes and cancer that can alter these biomarkers.

Objective

The aim of this study was to evaluate HbA1c and fructosamine as glycemic biomarkers in people with type 2 diabetes and cancer, undergoing clinical or surgical oncological treatment.

Methods

The authors conducted a single-center, retrospective analysis with people who have cancer and diabetes. Comparison of glycemic biomarkers (HbA1c, fructosamine, and Self-Monitoring of Blood Glucose [SMBG]) was performed including evaluation in individuals undergoing chemotherapy, using glucocorticoids, with anemia, hypoproteinemia or with reduced estimated Glomerular Filtration Rate (eGFR).

Results

There was a strong positive correlation between fructosamine and HbA1c (n = 318, r= 0.66, p < 0.001) in people with diabetes and cancer even in those under chemotherapy (n = 101, r= 0.61, p < 0.001) or using glucocorticoids (n = 96, r= 0.67, p

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2HypoalbuminemiaNeoplasmsDiabetes MellitusHumansGlycated HemoglobinFructosamineBlood GlucoseRetrospective StudiesGlycemic ControlGlucocorticoidsBiomarkers

Stichwörter der Autor:innen

CancerChemotherapyFructosamineGlucocorticoidsGlycemic controlHbA1c

Substanzen

Glycated HemoglobinFructosamineBlood GlucoseGlucocorticoidsBiomarkers

Autor:innen und Institutionen

  • Serviço de Onco-Endocrinologia, Instituto do Câncer do Estado de São Paulo Octávio Frias de Oliveira; Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, SP, Brazil. Electronic addres…
  • Serviço de Onco-Endocrinologia, Instituto do Câncer do Estado de São Paulo Octávio Frias de Oliveira; Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, SP, Brazil; Serviço de Endocr…
  • Departamento de Patologia, Faculdade de Medicina da Universidade de São Paulo, São Paulo, SP, Brazil.
  • Serviço de Onco-Endocrinologia, Instituto do Câncer do Estado de São Paulo Octávio Frias de Oliveira; Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, SP, Brazil.
  • Serviço de Endocrinologia e Metabologia. Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, SP, Brazil.
  • Serviço de Endocrinologia e Metabologia. Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, SP, Brazil; Hospital Israelita Albert Einstein, São Paulo, SP, Brazil.

Förderung

  • Endocrine Society

Zitieren

APA

Toyoshima, M. T. K., Cukier, P., Damascena, A. S., Batista, R. L., de Azevedo Correa, F., Zanatta Kawahara, E., Minanni, C. A., Hoff, A. O., & Nery, M. (2023). Fructosamine and glycated hemoglobin as biomarkers of glycemic control in people with type 2 diabetes mellitus and cancer (GlicoOnco study). Clinics, 78, 100240. https://doi.org/10.1016/j.clinsp.2023.100240

Vancouver

Toyoshima MTK, Cukier P, Damascena AS, Batista RL, de Azevedo Correa F, Zanatta Kawahara E, et al. Fructosamine and glycated hemoglobin as biomarkers of glycemic control in people with type 2 diabetes mellitus and cancer (GlicoOnco study). Clinics. 2023;78:100240. doi:10.1016/j.clinsp.2023.100240

BibTeX
@article{Toyoshima2023,
  author = {Toyoshima, Marcos Tadashi Kakitani and Cukier, Priscilla and Damascena, Aline Santos and Batista, Rafael Loch and de Azevedo Correa, Fernanda and Zanatta Kawahara, Eduardo and Minanni, Carlos André and Hoff, Ana O and Nery, Marcia},
  title = {Fructosamine and glycated hemoglobin as biomarkers of glycemic control in people with type 2 diabetes mellitus and cancer (GlicoOnco study)},
  journal = {Clinics},
  year = {2023},
  volume = {78},
  pages = {100240},
  doi = {10.1016/j.clinsp.2023.100240}
}
Kostenlos starten →